Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease

NCT02496884 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT02496884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02496884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
June 26, 2015
Completion date
July 6, 2017
Enrollment
56 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia